"Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
| Descriptor ID |
D009374
|
| MeSH Number(s) |
C04.619 E05.598.500.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Experimental".
- Neoplasms, Experimental
- Carcinoma 256, Walker
- Carcinoma, Brown-Pearce
- Carcinoma, Ehrlich Tumor
- Carcinoma, Krebs 2
- Carcinoma, Lewis Lung
- Leukemia, Experimental
- Liver Neoplasms, Experimental
- Mammary Neoplasms, Experimental
- Melanoma, Experimental
- Sarcoma, Experimental
This graph shows the total number of publications written about "Neoplasms, Experimental" by people in this website by year, and whether "Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 5 | 4 | 9 |
| 1995 | 7 | 4 | 11 |
| 1996 | 6 | 9 | 15 |
| 1997 | 3 | 4 | 7 |
| 1998 | 11 | 6 | 17 |
| 1999 | 11 | 6 | 17 |
| 2000 | 6 | 10 | 16 |
| 2001 | 4 | 3 | 7 |
| 2002 | 11 | 7 | 18 |
| 2003 | 6 | 8 | 14 |
| 2004 | 5 | 6 | 11 |
| 2005 | 6 | 8 | 14 |
| 2006 | 6 | 9 | 15 |
| 2007 | 9 | 11 | 20 |
| 2008 | 6 | 9 | 15 |
| 2009 | 8 | 7 | 15 |
| 2010 | 9 | 8 | 17 |
| 2011 | 9 | 6 | 15 |
| 2012 | 4 | 5 | 9 |
| 2013 | 3 | 6 | 9 |
| 2014 | 2 | 9 | 11 |
| 2015 | 1 | 8 | 9 |
| 2016 | 10 | 6 | 16 |
| 2017 | 7 | 5 | 12 |
| 2018 | 10 | 6 | 16 |
| 2019 | 6 | 3 | 9 |
| 2020 | 4 | 7 | 11 |
| 2021 | 7 | 3 | 10 |
| 2022 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Experimental" by people in Profiles.
-
Sox9 directs divergent epigenomic states in brain tumor subtypes. Proc Natl Acad Sci U S A. 2022 07 19; 119(29):e2202015119.
-
Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene. JCI Insight. 2022 02 22; 7(4).
-
Intravital deep-tumor single-beam 3-photon, 4-photon, and harmonic microscopy. Elife. 2022 02 15; 11.
-
Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Int J Mol Sci. 2022 Jan 31; 23(3).
-
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model. J Nanobiotechnology. 2021 Dec 11; 19(1):416.
-
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway. J Exp Med. 2022 01 03; 219(1).
-
Estrogen Inhibits Epithelial Progesterone Receptor-Dependent Progestin Therapy Efficacy in a Mouse Model of Cervical Cancer. Am J Pathol. 2022 02; 192(2):353-360.
-
Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor. J Med Chem. 2021 10 28; 64(20):15141-15169.
-
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021 09 09; 138(10):858-870.
-
DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight. 2021 09 08; 6(17).